Clinical Neuroscience and therapeutics in Schizophrenia is a high yield branch of medicine that involves the identification of any sign of delusions, hallucination, disorganized thinking or negative symptoms through appearance or behaviour. There are no clinical tests to specifically diagnose schizophrenia.It is a completely different and complex disorder that requires the immediate attention of a psychiatrist or a specialist. Even there is no single cause to get diagnosed with schizophrenia. Multiple causes like stress, genetic makeup, bipolar disorder, defects in how the brain thinks or forms a person's personality are responsible for this chronic neuropsychiatric disorder.  And what makes it worse is having no specified cure. Guided treatment plans and different kinds of antipsychotic medications are preferred to manage the illness. In most severe cases, the use of ECT is recommended. But there are numerous side effects of these treatment regimens. To address these converse, many research studies have been happening in this field. These include Recognition of the Adenine transdermal system for the treatment and addition of a new agent that is Lumateperone Tosylate. Few agents are still in the development phase, which makes this discipline popular among researchers. Thus the constant strive for accuracy in diagnostic tests has propelled the need for this discipline in many areas. 

Post-doctorate in clinical neuroscience and therapeutic in schizophrenia is a thoroughly guided and highly supervised course. The purpose of the programme is to support quality content and research studies that are done by scholars. It is aimed at fellows wishing for career advancement in the speciality of the mental health medical system. The programme is designed in such a manner that the fellows’ expertise or knowledge in all aspects of Schizophrenia will be required for academic assistance. The Postdoctoral fellowship is committed to promote new research studies and increase public awareness along with sharing existing knowledge. It aims to contribute to existing theoretical knowledge in Schizophrenia and to generate fieldwork-based data for policymaking in the domain of mental health. Because of the growing number of cases and complexities in identifying symptoms,  it has become essential to conduct research studies in the essential principles of schizophrenia so that they can render their consultative assistance too. It is expected that fellows will be committed to conducting full-time research on the different aspects of schizophrenia. During the course, the students will gain proficiency in many aspects of medical science and will be able to cater to the needs of the patient in alliance with the legal and professional ethical methods. The program is designed in such a manner that it demands participation in presentation, publication, research conferences, teaching, academic workshop, and seminars. The program also focuses on providing professional skills along with research skills. Overall, the programs prepare the fellows to develop expertise in advanced clinical skills and research to overcome the challenges of Schizophrenia. 

The course can be taken by the candidates who have completed MD in psychiatry or DNB in Psychiatry or equivalent from a recognized university. Seats are offered under two categories. The first category is the ‘institute stipendiary category’, the second category is the ‘sponsored ' category. The postdoctoral fellowship programme takes around 2 years to get completed. A career in this field is very promising as one can seek employment in many sectors as a researcher. They work with various organizations in policymaking. They get to participate in a review process related to studies.